Narcolepsy, with or without cataplexy, can have a substantial detrimental effect on well-being and quality of life. Because there is no cure for this condition, current treatments aim to improve ...
SAN DIEGO -- AXS-12 (reboxetine), an investigational treatment for narcolepsy, reduced weekly cataplexy attacks and in some cases provided complete remission, the phase III SYMPHONY study showed. From ...
Axsome's AXS-12 met its primary endpoint in a Phase 3 study, significantly reducing cataplexy attacks in narcolepsy patients, positioning it for an NDA submission. The narcolepsy market is substantial ...
Hosted on MSN
Excessive daytime sleepiness: When it could be narcolepsy; causes, treatment options, and lifestyle care
Narcolepsy can be described as a neurological condition that has chronic consequences on the regulation of the sleep-wake cycle by the brain. Narcolepsy has been known to occur in one out of every two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results